Henk A. Bremer

Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial

Kim Broekhuijsen, Gert‐Jan van Baaren, Maria G. van Pampus et al. · The Lancet · 2015 · 204 citations

Public Health, Maternal Health, Obstetrics +13

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial

Ingrid M. Bistervels, Andréa Buchmuller, Hanke M.G. Wiegers et al. · The Lancet · 2022 · 111 citations · Full text

Medicine, Obstetrics, Pharmacotherapy +16

Effects on (neuro)developmental and behavioral outcome at 2 years of age of induced labor compared with expectant management in intrauterine growth-restricted infants: long-term outcomes of the DIGITAT trial

Linda van Wyk, Kim Boers, Joris van der Post et al. · American Journal of Obstetrics and Gynecology · 2012 · 99 citations

Medicine, Obstetrics, Pediatrics +17

Neonatal morbidity after induction vs expectant monitoring in intrauterine growth restriction at term: a subanalysis of the DIGITAT RCT

Kim Boers, Linda van Wyk, Joris van der Post et al. · American Journal of Obstetrics and Gynecology · 2012 · 77 citations · Full text

Medicine, Obstetrics, Pediatrics +17

Bioactive tumour necrosis factor α in pre‐eclamptic patients with and without the HELLP syndrome

W. Edward Visser, Ilse Beckmann, Henk A. Bremer et al. · BJOG An International Journal of Obstetrics & Gynaecology · 1994 · 58 citations

Public Health, Endocrinology, Early Detection +8